Chronic Respiratory Disease, Copd
Conditions
Keywords
telemonitoring, chatbot, multimodal intervention
Brief summary
The investigators aim to investigate the effects of a telemonitoring and chatbot-based application of Living well with COPD (CAir) on health-related quality-of-life in patients with COPD.
Detailed description
The disease management programme Living well with COPD was developed to relieve symptoms and prevent exacerbations. It covers a disease self-management approach, educational topics, lifestyle coaching and physical activity advice. Future implications should aim to make the intervention easily accessible for a broad spectrum of patients at scalable costs. Patients need an engaging communication platform which can inform, coach and even listen in between medical visits. The inclusion of a chatbot agent may provide this tailored feedback. The investogator's aim is to investigate the effects of a telemonitoring and chatbot-based application of Living well with COPD on health-related quality-of-life in patients with COPD.
Interventions
COMBINATION_PRODUCTCAir
The CAir desk is a custom-built home disease monitoring device. The device consists of a smartphone (A320 \[2017\], Samsung Group, Seoul, Korea), home spirometer (Air Next Spirometer, NuvoAir, Stockholm, Sweden), physical activity tracker (Charge 3, Fitbit Inc., San Francisco CA, USA), and an air-quality monitor (Foobot, Airboxlab, Esch sur Alzette, Luxembourg). The components of the CAir desk are CE-certified.
Sponsors
University of Zurich
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Intervention model description
We will perform a 2:1 randomised, two-arm, single (assessor)-blind, monocentric trial.
Eligibility
Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No
Inclusion criteria
• Diagnosed COPD according to GOLD-guidelines
Exclusion criteria
* Physical or intellectual impairment precluding informed consent or protocol adherence * Non-German speaking * Acute or recent (within the last 6 weeks) exacerbation of COPD * Attending a pulmonary rehabilitation program within the last 3 months * Pregnant patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Health-related quality-of-life (HrQoL) | 3 months | St. George Respiratory Questionnaire (SGRQ). Scoring: Scores range from 0 to 100, with higher scores indicating more limitations. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Symptom burden | 3 months | COPD Assessment Test (CAT). Scoring: Scores range from 0-40, with higher scores indicating more symptoms. |
| Spirometry | 3 months | Forced expiratory volume in one second (FEV1) in liters and percent predicted. |
| Accelerometry | 3 months | Daily step count (number of steps) |
| Functional exercise capacity | 3 months | Six-minute walk test (6MWT) in meters walked. |
Countries
Switzerland
Outcome results
None listed